The American Society of Tropical Medicine and Hygiene has waived the Open Access fee for this article due to the ongoing COVID-19 pandemic and has assisted with publication expenses.
World Health Organization , 2020. Clinical Management of Severe Acute Respiratory Infection When COVID-19 Is Suspected. Geneva, Switzerland: WHO, 1–82. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed May 23, 2020.
Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA, 2020. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis 7: 1–7.
Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY, 2021. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 4: 1–9.
Abayomi A et al., 2021. Presenting symptoms and predictors of poor outcomes among 2,184 patients with COVID-19 in Lagos State, Nigeria. Int J Infect Dis 102: 226–232.
Elimian KO et al., 2020. Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study. BMJ Open 10: 44079.
Elimian KO et al., 2020. Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February–6 June 2020. Epidemiol Infect 148: e208.
Osikomaiya B et al., 2021. “Long COVID”: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect Dis 21: 304.
Nigeria Centre of Disease Control , 2020. National Interim Guidelines for Clinical Management of COVID-19. Available at: https://www.ncdc.gov.ng/themes/common/docs/protocols/177_1584210847.pdf. Accessed April 25, 2021.
Weerahandi H et al., 2021. Post-discharge health status and symptoms in patients with severe COVID-19. J Gen Intern Med 36: 738–745.
Moreno-Pérez O et al., 2021. Post-acute COVID-19 syndrome: incidence and risk factors: a Mediterranean cohort study. J Infect 82: 378–383.
Roberts LN, Whyte MB, Georgiou L, Giron G, Czuprynska J, Rea C, Vadher B, Patel RK, Gee E, Arya R, 2020. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood 136: 1347–1350.
Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI, 2020. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood 136: 1342–1346.
Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM, 2021. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerv Surg 13: 202–206.
Datta PK, Liu F, Fischer T, Rappaport J, Qin X, 2020. SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics 10: 7448–7464.
Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA, 2021. The dynamic association between COVID-19 and chronic disorders: an updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 87: 104647.
Halpin SJ et al., 2021. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 93: 1013–1022.
Garrigues E et al., 2020. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 81: e4–e6.
Ledford H, 2021. COVID reinfections are unusual, but could still help the virus to spread. Nature. Available at: https://www.nature.com/articles/d41586-021-00071-6. Accessed April 25, 2021.
Hansen CH, Michlmayr D, Gubbels SM, Mølbak K, Ethelberg S, 2021. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet 397: 1204–1212.